TMDX EBITDA Growth
Transmedics Group Inc · EBITDA Growth
TMDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.33%period ending
TMDX TTM EBITDA YoY % (-3.14% → 16.33%)
Year-over-year change
High-resolution chart · PNG
TMDX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 16.3254% | |
| 62.6175% | |
| 111.9848% | |
| 103.8748% | |
| 268.2908% | |
| 564.2034% | |
| 1,009.347% | |
| 379.8361% | |
| 507.0032% | |
| 164.3024% | |
| 73.4022% | |
| 35.1632% | |
| 82.026% | |
| 51.0022% | |
| 24.7532% | |
| -11.1184% | |
| -70.4854% | |
| -84.6185% | |
| -66.2261% | |
| -23.7636% | |
| 16.3859% | |
| 25.4008% | |
| 17.1058% | |
| 1.9126% | |
| -24.2254% | |
| -38.8635% | |
| -36.0016% | |
| -42.9057% | |
| -21.5951% | |
| -12.5557% | |
| -3.1412% |